Skip to main content
Institut national de santé publique du Québec
Français
FR
Main navigation
The Institute
The Institute
About us
About us
Products and services offered
Back
Contact us
Contact us
Workplaces
Back
Exit
Back
Expertise
Expertise
Information management and analysis
Information management and analysis
Deprivation
Deprivation
Indices of multiple and multidimensional deprivation
Material and Social Deprivation Index
Material and Social Deprivation Index
Methodological documents MSDI
Back
Back
Health of linguistic communities
Health of linguistic communities
Health Profile of Linguistic Communities in Québec
Back
Back
Individual and community development
Individual and community development
Perinatal and early childhood
Perinatal and early childhood
From Tiny Tot to Toddler
Back
Back
Lifestyles and prevention of chronic illnesses
Lifestyles and prevention of chronic illnesses
Healthy eating and active lifestyle
Healthy eating and active lifestyle
Health-promoting environments
Health-promoting environments
Built environment
Built environment
EffICAS - Toolbox
EffICAS - Toolbox
Carrying out a food access diagnosis
Establishing a food co-op
Evaluating the process of establishing a food co-op
Evaluating the impact of a food co-op
About the toolbox
Identifying food deserts
Evaluating the effects of establishing a food co-op
Back
Back
Back
TOPO
Back
Psychoactive substances, tobacco and gambling
Psychoactive substances, tobacco and gambling
Drugs and medicines
Drugs and medicines
Opioid overdoses
Opioid overdoses
Resources that can provide Naloxone
Naloxone administration
Back
Back
Tobacco and electronic cigarettes
Tobacco and electronic cigarettes
Science Watch : Tobacco Control
Back
Back
Back
Laboratories and testing services
Laboratories and testing services
Centre de toxicologie du Québec
Centre de toxicologie du Québec
About the CTQ
About the CTQ
Contact us
Back
Services
Services
Test catalog
Shipping samples
Shipping samples
Blood
Plasma or Serum
Urine
Biological Tissue
Back
Analysis request forms
Back
External quality assessment schemes
External quality assessment schemes
AMAP: AMAP Ring Test for Persistent Organic Pollutants in Human Serum
Creatinine: Interlaboratory Comparison Program for Measurement of Serum Creatinine
OSEQAS: External Quality Assessment Scheme for Organic Substances in Urine
PCI: Interlaboratory Comparison Program for Metals in Biological Matrices
QMEQAS: Quebec Multielement External Quality Assessment Scheme
Back
Back
Back
Infectious diseases
Infectious diseases
Prevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections
Nosocomial infections
Nosocomial infections
Provincial Monitoring (SPIN)
Provincial Monitoring (SPIN)
Hospital-Wide Healthcare-associated Bloodstream Infections
Hospital-Wide Healthcare-associated Bloodstream Infections
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Central Line–Associated Bloodstream Infections in Intensive Care Units
Central Line–Associated Bloodstream Infections in Intensive Care Units
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Vascular Access–Related Bloodstream Infections in Hemodialysis Patients
Vascular Access–Related Bloodstream Infections in Hemodialysis Patients
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Clostridium difficile–Associated Diarrhea (CDAD)
Clostridium difficile–Associated Diarrhea (CDAD)
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Carbapenemase-Producing Gram Negative Bacilli (CPGNB) Infections
Carbapenemase-Producing Gram Negative Bacilli (CPGNB) Infections
Previous years
Previous years
2016-2017
2015-2016
2014-2015
Back
Back
Vancomycin-Resistant Enterococci (VRE) Infections
Vancomycin-Resistant Enterococci (VRE) Infections
Previous years
Previous years
2016-2017
2015-2016
2014-2015
2013-2014
Back
Back
Back
Back
Medical Device Reprocessing
Blood-Borne Infection Risk Assessment Unit
Blood-Borne Infection Risk Assessment Unit
Assessment Process
Assessment Request Pathway
Exposure-Prone Procedures and Limitation Thresholds
Rights and Responsibilities
SERTIH's Team
For More Information
Promotional toolkit
Back
Back
Surveillance, prevention and control of infectious diseases
Surveillance, prevention and control of infectious diseases
COVID-19 (coronavirus)
COVID-19 (coronavirus)
Vaccination
Infection prevention and control
Occupational health
Environment and public places
Back
Back
Zoonoses and emerging diseases
Zoonoses and emerging diseases
Diseases transmitted by ticks
Diseases transmitted by ticks
Identification guide for ticks found in Québec
Informative pamphlets: Lyme disease in the workplace
Back
Back
Back
Occupational health
Occupational health
Work-related respiratory diseases
Work-related respiratory diseases
Asbestos
Asbestos
Additional information on Asbestos in Québec
Back
Back
Psychosocial risks in the workplace and health promotion
Psychosocial risks in the workplace and health promotion
Psychosocial risks in the workplace
Back
Back
Indigenous Health
Indigenous Health
Research Monitoring
Research Monitoring
Methodology for Indigenous Health Research Monitoring
Back
Nunavik Inuit Health Survey 2004
Back
Environmental health and toxicology
Environmental health and toxicology
Water, food, soil and products
Water, food, soil and products
Per- and polyfluoroalkyl substances (PFAS)
Back
Air quality, environmental noise and non-ionizing radiation
Air quality, environmental noise and non-ionizing radiation
Air quality
Air quality
Indoor air
Indoor air
Mould compendium
Mould compendium
Moulds fact sheets
Your health
Your home
Terms of use
Back
Back
Back
Back
Back
Safety, violence and injury prevention
Safety, violence and injury prevention
Community safety promotion
Community safety promotion
Methods and tools
Methods and tools
Charting a course to safe living collection
Back
Back
Prevention of interpersonal violence
Prevention of interpersonal violence
Sexual Violence
Sexual Violence
Media
Media
Best practices
Media and prevention
Back
Understanding
Understanding
Forms of sexual violence
Myths and Facts
Risk Factors
Risk Factors
Risk of being sexually abused during childhood
Risk of being sexually assaulted during adulthood
Risk of committing sexual assault
Back
Consequences
Consequences
Child sexual absuse
Adult sexual assault
On society
Back
Back
Prevention
Prevention
Individual and Relationship Strategies
Community and Societal Strategies
Back
Statistics
Statistics
Prevalence among youth
Prevalence among adults
Sources
Back
Perpetration of sexual violence
Perpetration of sexual violence
Sexual Assault by Women
Recidivism Among Perpetrators of Sexual Assault
Back
Disclosure of sexual violence
Disclosure of sexual violence
Disclosure process
Childhood sexual absuse
Adult sexual violence
Disclosures on social media
False Allegations of Child Sexual Abuse
Back
Contexts
Contexts
Sexual harassment in the workplace
Online Pedophilia and Cyberspace
Young athletes
Sexual Abuse in the Childhood of Perpetrators
Back
Legislation and sexual offences
Legislation and sexual offences
Legal Framework
Criminal Justice Process
Offences under the Criminal Code
Back
Resources
About
About
Redaction and financial support
Back
Back
Rapport québécois sur la violence et la santé
Back
Back
Exit
Back
Publications
Publications
Publications
Subscribe to INSPQ's mailing lists
Exit
Back
Search
Search
Search
Open search
Main navigation toggle
Michel Alary
Publications
INSPQ
2023
Surveillance des maladies infectieuses chez les personnes qui utilisent des drogues par injection
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport 2021
2022
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport 2020
2021
Surveillance des maladies infectieuses chez les utilisateurs de drogues par injection - Épidémiologie du VIH 1995-2018 - Épidémiologie du VHC 2003-2018
2020
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport 2019
2019
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport annuel 2018
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport annuel 2017
Surveillance des maladies infectieuses chez les utilisateurs de drogues par injection - Épidémiologie du VIH 1995-2017 - Épidémiologie du VHC 2003-2017
2018
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection - Épidémiologie du VIH de 1995 à 2016 - Épidémiologie du VHC de 2003 à 2016
2017
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport annuel 2016
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : Épidémiologie du VIH de 1995 à 2015 – Épidémiologie du VHC de 2003 à 2015
2016
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec - Rapport annuel 2015
Surveillance des maladies infectieuses chez les utilisateurs de drogues par injection – Épidémiologie du VIH de 1995 à 2014 – Épidémiologie du VHC de 2003 à 2014
2015
Programme de surveillance de l’infection par le virus de l’immunodéficience humaine (VIH) au Québec : rapport annuel 2014
2014
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : rapport annuel 2013
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection - Épidémiologie du VIH de 1995 à 2012 - Épidémiologie du VHC de 2003 à 2012
2013
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2012
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2012
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection – Épidémiologie du VIH de 1995 à 2010 – Épidémiologie du VHC de 2003 à 2010
2012
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2011
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2011
2011
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2010
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection – Épidémiologie du VIH de 1995 à 2009 - Épidémiologie du VHC de 2003 à 2009
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2010
2010
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2009
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2009
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection – Épidémiologie du VIH de 1995 à 2008 – Épidémiologie du VHC de 2003 à 2008
2009
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2008
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2008
2008
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2007
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : épidémiologie du VIH de 1995 à 2007 : épidémiologie du VHC de 2003 à 2007
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : mise à jour des données au 30 juin 2007
Évaluation du programme québécois de gratuité des médicaments pour le traitement des infections transmissibles sexuellement, de 2000 à 2004
2007
Programme de surveillance de l'infection (PSI) par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2006
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection - Épidémiologie du VIH de 1995 à 2006 - Épidémiologie du VHC de 2003 à 2006
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas déclarés de janvier à juin 2006 et cumulatifs avril 2002-juin 2006
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : épidémiologie du VIH de 1995 à 2005 / Épidémiologie du VHC de 2003 à 2005
2006
Programme de surveillance de l'infection par le virus de l'immunodéficience humaine (VIH) au Québec : cas cumulatifs 2002-2005
Infectious diseases surveillance among injection drug users - Epidemiology of HCV from 1997 to 2003 - A retrospective look
Infectious diseases surveillance among injection drug users - Epidemiology of HCV from 1997 to 2003 - A retrospective look
Infectious diseases surveillance among injection drug users - Epidemiology of HIV from 1995 to 2004 - Epidemiology of HCV from 2003 to 2004
Infectious diseases surveillance among injection drug users - Epidemiology of HIV from 1995 to 2004 - Epidemiology of HCV from 2003 to 2004
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : épidémiologie du VHC de 1997 à 2003 : un regard rétrospectif
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : épidémiologie du VHC de 1997 à 2003 : un regard rétrospectif
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : Épidémiologie du VIH de 1995 à 2004 - Épidémiologie du VHC de 2003 à 2004
Surveillance des maladies infectieuses chez les utilisateurs de drogue par injection : Épidémiologie du VIH de 1995 à 2004 - Épidémiologie du VHC de 2003 à 2004
Articles
2023
HIV Replication Increases the Mitochondrial DNA Content of Plasma Extracellular Vesicles
2022
Measuring progress towards reaching zero new HIV acquisitions among key populations in Québec (Canada) using routine surveillance data: a mathematical modelling study
HIV self-testing implementation, distribution and use among female sex workers in Cotonou, Benin: a qualitative evaluation of acceptability and feasibility
Vesicular MicroRNA as Potential Biomarkers of Viral Rebound
Monocyte Gene and Molecular Expression Profiles Suggest Distinct Effector and Regulatory Functions in Beninese HIV Highly Exposed Seronegative Female Commercial Sex Workers
Plasma vesicular miR-155 as a biomarker of immune activation in antiretroviral treated people living with HIV
2021
Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis
Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
Diurnal Variation of Plasma Extracellular Vesicle Is Disrupted in People Living with HIV
Type-Specific Incidence, Persistence and Factors Associated with Human Papillomavirus Infection among Female Sex workers in Benin and Mali, West Africa
Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
HIV prevention and treatment cascades among female sex workers in Benin, West Africa
Plasma Extracellular Vesicle Subtypes May be Useful as Potential Biomarkers of Immune Activation in People With HIV
2020
Human papillomavirus genotype distribution and factors associated among female sex workers in West Africa
A mathematical model impact analysis of a real-life pre-exposure prophylaxis and treatment-as-prevention study among female sex workers in Cotonou, Benin
Prevalence and Factors Associated With HIV and Sexually Transmitted Infections Among Female Sex Workers in Bamako, Mali
Natural killer cell phenotype is altered in HIV-exposed seronegative women
Pre-exposure prophylaxis among men who have sex with men in Côte d'Ivoire: a quantitative study of acceptability
Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in Benin
TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells
HIV treatment response among female sex workers participating in a treatment as prevention demonstration project in Cotonou, Benin
2019
Cost-Effectiveness of Accelerated HIV Response Scenarios in Côte d'Ivoire
PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation
Natural Immunity to HIV is associated with Low BLyS/BAFF levels and low frequencies of innate marginal zone like CD1c+ B-cells in the genital tract
Trends and risk factors associated with the perpetration of physical intimate partner violence by women in Haiti, 2000-2012
Biological Validation of Self-Reported Unprotected Sex and Comparison of Underreporting Over Two Different Recall Periods Among Female Sex Workers in Benin
A novel nested polymerase chain reaction targeting the testis-specific protein Y-encoded family of genes for high sensitivity of recent semen exposure detection: Comparison with four other assays of semen detection
Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up
2018
Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
Développement et implantation d'une intervention ciblée encourageant le dépistage régulier du VIH chez les travailleuses du sexe au Bénin : application du protocole d' intervention mapping
HIV and hepatitis C virus infections in Quebec's provincial detention centres: comparing prevalence and related risky behaviours between 2003 and 2014-2015
Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system
Anal Intercourse Among Female Sex Workers in Cote d'Ivoire: Prevalence, Determinants, and Model-Based Estimates of the Population-Level Impact on HIV Transmission.
Gonorrhea, Chlamydia and HIV incidence among female sex workers in Cotonou, Benin: A longitudinal study
Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study
2017
Antimicrobial susceptibility profile of Neisseria gonorrhoeae isolated in Cotonou, Benin (2015-2017).
Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs.
Population-level impact of an accelerated HIV response plan to reach the UNAIDS
2016
Sex Work as an Emerging Risk Factor for Human Immunodeficiency Virus Seroconversion Among People who Inject Drugs in the SurvUDI Network.
2010
A randomized trial to evaluate the efficacy of a computer-tailored intervention to promote safer injection practices among drug users
2005
Lack of evidence of sexual transmission of hepatitis C virus in a prospective cohort study of men who have sex with men
